FDA
label_change
· 2016-08-26
FDA Approved: NORTREL 7/7/7 (28 DAY REGIMEN) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Nortrel 7/7/7 (28 day regimen), updating labeling to reflect a 28-day regimen for norethindrone and ethinyl estradio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORTREL 7/7/7 (28 DAY REGIMEN) (NORETHINDRONE AND ETHINYL ESTRADIOL)